John Rouse, who obtained his PhD with Philip Cohen in 1996, is rejoining the Unit in October 2002 as a Programme Leader. For the past six years John has been a Postdoctoral Fellow with Professor Steve Jackson at the Wellcome/CRC Institute in Cambridge, England. His group will study the protein kinases that control the DNA damage checkpoint.